» Authors » Martin Aepfelbacher

Martin Aepfelbacher

Explore the profile of Martin Aepfelbacher including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 168
Citations 7134
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
31.
Hermanussen L, Grewe I, Tang H, Norz D, Bal L, Pfefferle S, et al.
J Med Virol . 2022 Sep; 95(1):e28181. PMID: 36177717
No abstract available.
32.
Heyer A, Gunther T, Robitaille A, Lutgehetmann M, Addo M, Jarczak D, et al.
Cell Rep Med . 2022 Sep; 3(9):100735. PMID: 36075217
We here investigate the impact of antiviral treatments such as remdesivir on intra-host genomic diversity and emergence of SARS-CoV2 variants in patients with a prolonged course of infection. Sequencing and...
33.
Norz D, Brehm T, Tang H, Grewe I, Hermanussen L, Matthews H, et al.
J Clin Virol . 2022 Sep; 155:105254. PMID: 36057206
Background: The ongoing monkeypox virus outbreak includes at least 7553 confirmed cases in previously non-endemic countries worldwide as of July 2022. Clinical presentation has been reported as highly variable, sometimes...
34.
Moreno-Layseca P, Jantti N, Godbole R, Sommer C, Jacquemet G, Al-Akhrass H, et al.
Nat Cell Biol . 2022 Aug; 24(9):1445. PMID: 36038735
No abstract available.
35.
Olearo F, Radmanesh L, Felber N, von Possel R, Emmerich P, Pekarek N, et al.
J Reprod Immunol . 2022 Aug; 153:103685. PMID: 36029724
Breast milk is a pivotal source to provide passive immunity in newborns over the first few months of life. Very little is known about the antibody transfer levels over the...
36.
Stamm J, Weisselberg S, Both A, Failla A, Nordholt G, Buttner H, et al.
Front Cell Infect Microbiol . 2022 Aug; 12:948151. PMID: 35967857
is a major causative agent of prosthetic joint infections (PJI). The ability to form biofilms supports this highly selective pathogenic potential. studies essentially relying on phenotypic assays and genetic approaches...
37.
Norz D, Tang H, Emmerich P, Giersch K, Fischer N, Schmiedel S, et al.
Emerg Infect Dis . 2022 Jul; 28(9):1765-1769. PMID: 35905463
Beginning in May 2022, a rising number of monkeypox cases were reported in non-monkeypox-endemic countries in the Northern Hemisphere. We adapted 2 published quantitative PCRs for use as a dual-target...
38.
Brehm T, Ullrich F, Thompson M, Kuchen J, Schwinge D, Spier A, et al.
Vaccines (Basel) . 2022 Jul; 10(7). PMID: 35891249
Background: The immunogenicity of different COVID-19 vaccine regimens and combinations in naïve and convalescent individuals has not been formally tested in controlled studies, and real-life observational studies are scarce. Methods:...
39.
Norz D, Pfefferle S, Brehm T, Franke G, Grewe I, Knobling B, et al.
Euro Surveill . 2022 Jul; 27(26). PMID: 35775427
The extent of monkeypox virus environmental contamination of surfaces is unclear. We examined surfaces in rooms occupied by two monkeypox patients on their fourth hospitalisation day. Contamination with up to...
40.
Czech-Sioli M, Gunther T, Robitaille A, Roggenkamp H, Buttner H, Indenbirken D, et al.
Clin Infect Dis . 2022 Jun; 76(3):e263-e273. PMID: 35717654
Background: The ongoing coronavirus disease 2019 pandemic significantly burdens hospitals and other healthcare facilities. Therefore, understanding the entry and transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is critical...